Delivery Order SPE2DB25D7068-SPE2DB25FTYCJ
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Refresh Plus 0.5% eye drops (30-count units) with a contract value of $1,476.04. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a $1,740.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units). Issued on September 16, 2025, with an ultimate completion date of September 17, 2025, this competitively awarded contract required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,147.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (50-count unit dose) on April 24, 2025, with a completion date of April 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,380.63 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Refresh Plus 0.5% eye drops in unit dose packaging (70 units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of August 28, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,845.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) with a completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) with a ceiling value of $5,674.32 under a firm fixed price contract type. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its Corporate Office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on August 7, 2025, for Refresh Plus 0.5% eye drops in unit dose packaging (50 count). The contract is valued at $1,583.61 with a firm fixed price structure and an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,290.00 for Refresh Plus 0.5% eye drops (30-unit package) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYCJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count) on September 23, 2025, with a ceiling value of $2,008.77 and a firm fixed price structure. This is a non-set-aside competitive award to be fulfilled at the company's Conshohocken, Pennsylvania location, with completion scheduled for September 24, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical supplier of medical commodities to federal military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal contract awards through open competition, demonstrating its capability to meet stringent federal procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/23/25 |